Org 10172 for heparin-induced thrombocytopenia: Tolerance and efficacity;Thrombopénie induite par l'héparine: Traitement par l'Org 10172 - Tolérance et efficacité

Presse Medicale

Volumn 25, Issue 16, 1996, Pages 751-755

  Tardy Poncet, B ^a,b   Reynaud, J ^a   Tardy, B ^a   Mahul, P ^a   Mismetti, P ^a   Beraud, A M ^a   Rebaud, M A ^a   Bayon, M ^a   Guyotat, D ^a  

^a HÔPITAL NORD   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; COUMARIN; DANAPAROID; HEPARIN; LYSINE ACETYLSALICYLATE; WARFARIN; ANTICOAGULANT AGENT; CHONDROITIN SULFATE; DERMATAN SULFATE; HEPARAN SULFATE;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; DRUG INDICATION; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; THROMBOCYTOPENIA; THROMBOSIS; CHEMICALLY INDUCED DISORDER; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; THROMBOCYTE COUNT; THROMBOEMBOLISM; TIME;

ADULT; AGED; ANTICOAGULANTS; CHONDROITIN SULFATES; DERMATAN SULFATE; FEMALE; HEPARIN; HEPARITIN SULFATE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PLATELET COUNT; THROMBOCYTOPENIA; THROMBOEMBOLISM; TIME FACTORS;

EID: 0029896921     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Schmitt BP, Adelman B Heparin-associated thrombocytopenia a critical review and a pooled analysis Am J Med Sci 1993; 305.208-15
2. Warkentm TE, Levine MN, Hirsh J et al Heparin-induced thrombocytopenia in patients with low-molecular-weight heparin or unfractionated heparin N Engl J Med 1995; 332:1330-5
3. King DJ, Kelton JG Heparin-associate thrombocytopenia. Ann Intern Med 1984; 100 536-40
4. Warkentin TE, Kelton JG Heparin-induced thrombocytopenia. Prog Ilemost Thromb 1991; 1:1-34
5. Meuleman DG, Orgaran (Org 10172). its pharmacological profile in experimental models. Haemostasis 1992, 22:58-65.
6. Nuimohamed MT, Fareed J, Hoppensteadt D, Walenga JM, Ten Cate JW. Pharmacological and clinical studies with Lomoparan, a low molecular weight glycoammoglycan Semin Thromb Hemost 1991; 17:205-13
7. Chong BH, Ismail F, Cade M, Gallus AS, Gordon S, Chesterman CN Heparin-induced thrombocytopenia: studies with a low molecular weight heparinoid, Org 10172 Blood 1989; 73:1592-6.
8. Chong BH, Magnani HN. Orgaran in heparin-induced thrombocytopenia. Haemostasis 1992, 22:85-91
9. Ortel TM, Gockerman JP, Califf RM et al. Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin-induced thrombocytopenia and thrombosis. Thromb Haemost 1992; 67:292-6
10. Magnani HN Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (Org 10172). Thromb Haemost 1993; 70:554-61.
11. Greinacher A, Michels I, Mueller-Ekhardt C. Heparin-associated thrombocytopenia: the antibody is non heparin specific Thromb Haemost 1992; 67:545-9.
12. Warkentin TE, Russett JI, Johnston M, Kelton JG. Warfarin treatment of deep vein thrombosis complicating heparin-induced thrombocytopenia (HIT) is a risk factor for initiation of venous lib gangrene: report of nine patients implicating the interacting procoagulant effects of two anticoagulant agents, Thromb Haemost 1995, 73:804 (Abstract).
13. De Valk HW, Banga JD, Wester JWJ et al. Comparing subcutaneous Danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. Ann Intern Med 1995; 123:1-9.
14. Boon DMS, Michiels JJ, Stibbe J, Van Vliet HHDM, Kappers-Klunne MC. Heparin induced thrombocytopenia and antithrombotic therapy Lancet 1994; 344:1296-300
15. Tardy-Poncet B, Mahul P, Beraud AM, Favre JP, Tardy B, Guyotat D. Failure of Orgaran therapy in a patient with a previous heparin induced thrombocytopenia Br J Haematol 1995; 90:969-70